Hormonal and metabolic strategies to attenuate catabolism in critically ill patients

Current Opinion in Pharmacology

Volumn 4, Issue 6, 2004, Pages 621-628

  Vanhorebeek, Ilse ^a   Van den Berghe, Greet ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOHYPOPHYSIS HORMONE; ANDROGEN; ARGININE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUTAMINE; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; HUMAN GROWTH HORMONE; HYPOTHALAMUS RELEASING FACTOR; INSULIN; LIOTHYRONINE; LUTEINIZING HORMONE; OXANDROLONE; PLACEBO; PROLACTIN; PROPRANOLOL; PROTIRELIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TESTOSTERONE; THYROID HORMONE; THYROTROPIN; THYROXINE; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; CACHEXIA; CARBOHYDRATE DIET; CLINICAL TRIAL; CRITICAL ILLNESS; DIET SUPPLEMENTATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; ENTERIC FEEDING; HORMONAL THERAPY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HYPERGLYCEMIA; HYPERMETABOLISM; IMMUNOPATHOLOGY; INFECTION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LONG TERM CARE; NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROLACTIN RELEASE; REVIEW; SIDE EFFECT; STRESS; THYROTROPIN RELEASE;

ANIMALS; BELGIUM; CACHEXIA; CRITICAL CARE; CRITICAL ILLNESS; ENERGY METABOLISM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; STRESS;

EID: 13944259483     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.07.007     Document Type: Review

References (72)

1. L. Gamrin K. Andersson E. Hultman E. Nilsson P. Essen J. Wernerman Longitudinal changes of biochemical parameters in muscle during critical illness Metabolism 46 1997 756-762
2. C.L. Reid I.T. Campbell R.A. Little Muscle wasting and energy balance in critical illness Clin Nutr 23 2004 273-280
3. B.F. Liu S. Miyata A. Kojima H. Kusunoki K. Suzuki M. Kasuga Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end procucts Diabetes 48 1999 2074-2082
4. A.P. Robin I. Arain A. Phuangsab O. Holian P. Roccaforte J.A. Barrett Intravenous fat emulsion acutely suppresses neutrophil chemiluminescence JPEN J Parenter Enteral Nutr 13 1989 608-613
5. A. Binnerts G.R. Swart J.H. Wilson N. Hoogerbrugge H.A. Pols J.C. Birkenhager S.W. Lamberts The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition Clin Endocrinol (Oxf) 37 1992 79-87
6. R.J. Ross J. Rodriguez-Arnao J. Bentham J.H. Coakley The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill Intensive Care Med 19 1993 S54-S57
7. J. Takala E. Ruokonen N.R. Webster M.S. Nielsen D.F. Zandstra G. Vundelinckx C.J. Hinds Increased mortality associated with growth hormone treatment in critically ill adults N Engl J Med 341 1999 785-792
8. G. Van den Berghe F. de Zegher R. Bouillon Acute and prolonged critical illness as different neuroendocrine paradigms J Clin Endocrinol Metab 83 1998 1827-1834
9. G. Van den Berghe Endocrine evaluation of patients with critical illness Endocrinol Metab Clin North Am 32 2003 385-410
10. F. Weekers E. Van Herck W. Coopmans M. Michalaki C.Y. Bowers J.D. Veldhuis G. Van den Berghe A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response Endocrinology 143 2002 764-774
11. G. Van den Berghe P. Wouters F. Weekers C. Verwaest F. Bruyninckx M. Schetz D. Vlasselaers P. Ferdinande P. Lauwers R. Bouillon Intensive insulin therapy in the critically ill patients N Engl J Med 345 2001 1359-1367
12. G. Van den Berghe P.J. Wouters R. Bouillon F. Weekers C. Verwaest M. Schetz D. Vlasselaers P. Ferdinande P. Lauwers Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control Crit Care Med 31 2003 359-366
13. Y.A. Debaveye G.H. Van den Berghe Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 98 2004 461-468
14. R. Ross J. Miell E. Freeman J. Jones D. Matthews M. Preece C. Buchanan Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I Clin Endocrinol (Oxf) 35 1991 47-54
15. M. Hermansson R.B. Wickelgren F. Hammarqvist R. Bjarnason I. Wennstrom J. Wernerman B. Carlsson L.M. Carlsson Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: Demonstration of reduced expression after elective surgery J Clin Endocrinol Metab 82 1997 421-428
16. D. Defalque N. Brandt J.M. Ketelslegers J.P. Thissen GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors Am J Physiol 276 1999 E565-E572
17. C. Rivier W. Vale Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin Nature 305 1983 325-327
18. V. Bacci G.C. Schussler T.B. Kaplan The relationship between serum triiodothyronine and thyrotropin during systemic illness J Clin Endocrinol Metab 54 1982 1229-1235
19. C. Wang V. Chan R.T. Yeung Effect of surgical stress on pituitary-testicular function Clin Endocrinol (Oxf) 9 1978 255-266
20. G. Van den Berghe F. de Zegher J.D. Veldhuis P. Wouters M. Awouters W. Verbruggen M. Schetz C. Verwaest P. Lauwers R. Bouillon C.Y. Bowers The somatotropic axis in critical illness: Effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion J Clin Endocrinol Metab 82 1997 590-599
21. G. Van den Berghe P. Wouters F. Weekers S. Mohan R.C. Baxter J.D. Veldhuis C.Y. Bowers R. Bouillon Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness J Clin Endocrinol Metab 84 1999 1311-1323
22. G. Van den Berghe R.C. Baxter F. Weekers P. Wouters C.Y. Bowers J.D. Veldhuis A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness J Clin Endocrinol Metab 85 2000 183-192
23. G. Van den Berghe F. de Zegher C.Y. Bowers P. Wouters P. Muller F. Soetens D. Vlasselaers M. Schetz C. Verwaest P. Lauwers R. Bouillon Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness Clin Endocrinol (Oxf) 45 1996 341-351
24. G. Van den Berghe F. de Zegher J.D. Veldhuis P. Wouters S. Gouwy W. Stockman F. Weekers M. Schetz P. Lauwers R. Bouillon C.Y. Bowers Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues Clin Endocrinol (Oxf) 47 1997 599-612
25. E. Fliers W.M. Wiersinga D.F. Swaab Physiological and pathophysiological aspects of thyrotropin-releasing hormone gene expression in the human hypothalamus Thyroid 8 1998 921-928
26. G. Van den Berghe R.C. Baxter F. Weekers P. Wouters C.Y. Bowers A. Iranmanesh J.D. Veldhuis R. Bouillon The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone Clin Endocrinol (Oxf) 56 2002 655-669
27. R.P. Peeters P.J. Wouters E. Kaptein H. van Toor T.J. Visser G. Van den Berghe Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients J Clin Endocrinol Metab 88 2003 3202-3211
28. F. Weekers M. Michalaki W. Coopmans E. Van Herck J.D. Veldhuis V.M. Darras G. Van den Berghe Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone and insulin infusion in a rabbit model of prolonged critical illness Endocrinology 145 2004 205-213
29. G. Van den Berghe F. Weekers R.C. Baxter P. Wouters A. Iranmanesh R. Bouillon J.D. Veldhuis Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness J Clin Endocrinol Metab 86 2001 3217-3226
30. J.S. Hadley C.J. Hinds Anabolic strategies in critical illness Curr Opin Pharmacol 2 2002 700-707
31. S.J. Streat A.H. Beddoe G.L. Hill Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients J Trauma 27 1987 262-266
32. D.K. Heyland S. MacDonald L. Keefe J.W. Drover Total parenteral nutrition in the critically ill patient: A meta-analysis JAMA 280 1998 2013-2019
33. R.D. Griffiths Is parenteral nutrition really that risky in the intensive care unit? Curr Opin Clin Nutr Metab Care 7 2004 175-181
34. F. Hammarqvist Can it all be done by enteral nutrition? Curr Opin Clin Nutr Metab Care 7 2004 183-187
35. D.L. Sigalet S.L. Mackenzie S.M. Hameed Enteral nutrition and mucosal immunity: Implications for feeding strategies in surgery and trauma Can J Surg 47 2004 109-116
36. D.W. Hart S.E. Wolf X.J. Zhang D.L. Chinkes M.C. Buffalo S.I. Matin M.A. DebRoy R.R. Wolfe D.N. Herndon Efficacy of a high-carbohydrate diet in catabolic illness Crit Care Med 29 2001 1318-1324
37. D. Kelly P.E. Wishmeyer Role of L-glutamine in critical illness: New insights Curr Opin Clin Nutr Metab Care 6 2003 217-222
38. D.N. Herndon D.W. Hart S.E. Wolf D.L. Chinkes R.R. Wolfe Reversal of catabolism by beta-blockade after severe burns N Engl J Med 345 2001 1223-1229
39. T.A. Hillier D.A. Fryburg L.A. Jahn E.J. Barrett Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm Am J Physiol 274 1998 E1067-E1074
40. D. Mesotten P.J. Delhanty F. Vanderhoydonc K.V. Hardman F. Weekers R.C. Baxter G. Van den Berghe Regulation of insulin-like growth factor binding protein-1 during protracted critical illness J Clin Endocrinol Metab 87 2002 5516-5523
41. X.J. Zhang D.L. Chinkes O. Irtun R.R. Wolfe Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids Am J Physiol Endocrinol Metab 282 2002 E1308-E1315
42. D. Mesotten P.J. Wouters R.P. Peeters K.V. Hardman J.M. Holly R.C. Baxter G. Van den Berghe Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness J Clin Endocrinol Metab 89 2004 3105-3113
43. D.L. Russell-Jones A.M. Umpleby T.R. Hennessy S.B. Bowes F. Shojaee-Moradie K.D. Hopkins N.C. Jackson J.M. Kelly R.H. Jones P.H. Sonksen Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans Am J Physiol 267 1994 E591-E598
44. N. Stathatos C. Levetan K.D. Burman L. Wartofsky The controversy of the treatment of critically ill patients with thyroid hormone Best Pract Res Clin Endocrinol Metab 15 2001 465-478
45. D.F. Gardner M.M. Kaplan C.A. Stanley R.D. Utiger Effect of tri-iodothyronine replacement on the metabolic and pituitary response to starvation N Engl J Med 300 1979 579-584
46. C.G. Acker A.R. Singh R.P. Flick J. Bernardini A. Greenberg J.P. Johnson A trial of thyroxine in acute renal failure Kidney Int 57 2000 293-298
47. A.A. Ferrando M. Sheffield-Moore S.E. Wolf D.N. Herndon R.R. Wolfe Testosterone administration in severe burns ameliorates muscle catabolism Crit Care Med 29 2001 1936-1942
48. R.H. Demling Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury Burns 25 1999 215-221
49. M.K. Angele A. Ayala W.G. Cioffi K.I. Bland I.H. Chaudry Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage Am J Physiol 274 1998 C1530-C1536
50. D.E. Cummings G.R. Merriam Growth hormone therapy in adults Annu Rev Med 54 2003 513-533
51. C. Costa G. Solanes J. Visa F. Bosch Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus FASEB J 12 1998 1455-1460
52. U. Keller J.M. Miles Growth hormone and lipids Horm Res 36 1991 36-40
53. P.M. Stewart A.A. Toogood J.W. Tomlinson Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle Horm Res 56 2001 1-6
54. J. Møller J.O. Jørgensen N. Møller J.S. Christiansen J. Weeke Effects of growth hormone administration on fuel oxidation and thyroid function in normal men Metabolism 41 1992 728-731
55. B.H. Shapiro A.K. Agrawal N.A. Pampori Gender differences in drug metabolism regulated by growth hormone Int J Biochem Cell Biol 27 1995 9-20
56. A. Cittadini H. Stromer S.E. Katz R. Clark A.C. Moses J.P. Morgan P.S. Douglas Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat. A combined in vivo and in vitro evaluation Circulation 93 1996 800-809
57. H. Saito T. Inoue K. Fukatsu L. Ming-Tsan T. Inaba R. Fukushima T. Muto Growth hormone and the immune response to bacterial infection Horm Res 45 1996 50-54
58. M.S. Dahn M.P. Lange L.A. Jacobs Insulin-like growth factor 1 production is inhibited in human sepsis Arch Surg 123 1988 1409-1414
59. R. Vara-Thorbeck J.A. Guerrero M.E. Ruiz-Requena J. Capitan M. Rodriguez J. Rosell K. Mekinassi M. Maldonado R. Martin Effects of growth hormone in patients receiving total parenteral nutrition following major gastrointestinal surgery Hepatogastroenterology 39 1992 270-272
60. R.S. Berman L.E. Harrison D.B. Pearlstone M. Burst M.F. Brennan Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery Ann Surg 229 1999 1-10
61. L. Gamrin P. Essen E. Hultman M. McNurlan P. Garlick J. Wernerman Protein sparing effect in skeletal muscle of growth hormone treatment in critically ill patients Ann surg 231 2000 577-586
62. J.B. Koea B.H. Breier R.G. Douglas P.D. Gluckman J.H. Shaw Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis Br J Surg 83 1996 196-202
63. D.A. Gilpin R.E. Barrow R.L. Rutan L. Broemeling D.N. Herndon Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns Ann Surg 220 1994 19-24
64. M. Mjaaland K. Unneberg J. Larsson L. Nilsson A. Revhaug Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition Ann Surg 217 1993 413-422
65. E. Ruokonen J. Takala Dangers of growth hormone therapy in critically ill patients Curr Opin Clin Nutr Metab Care 5 2002 199-209
66. M.J. O'Leary C.N. Fergusson M. Rennie C.J. Hinds J.H. Coakley V.R. Preedy Effect of growth hormone on muscle and liver protein synthesis in septic rats receiving glutamine-enriched parenteral nutrition Crit Care Med 30 2002 1099-1105
67. N.C. Jackson P.V. Carroll D.L. Russel-Jones P.H. Sönksen D.F. Treacher A.M. Umpebly Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients Am J Physiol Endocrinol Metab 278 2000 E226-E233
68. Y.K. Youn G.J. Suh S.E. Jung S.K. Oh R. Demling Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxidant activity after thermal injury in rats J Burn Care Rehabil 19 1998 542-548
69. P.V. Carroll N.C. Jackson D.L. Russel-Jones D.F. Treacher P.H. Sönksen A.M. Umpleby Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness Am J Physiol Endocrinol Metab 286 2004 E151-E157
70. W. Liao M. Rudling B. Angelin Growth hormone potentiates the in vivo biological activities of endotoxin in the rat Eur J Clin Invest 26 1996 254-258
71. K. Unneberg L. Balteskard M. Mjaaland A. Revhaug Growth hormone impaired compensation of hemorrhagic shock after trauma and sepsis in swine J Trauma 41 1996 775-780
72. Z. Liu Y. Yu Y. Jiang J. Li Growth hormone increases circulating neutrophil activation and provokes lung microvascular injury in septic peritonitis rats J Surg Res 105 2002 195-199